HEPATOCYTE GROWTH-FACTOR ENHANCEMENT OF PRENEOPLASTIC HEPATIC FOCI DEVELOPMENT IN RATS TREATED WITH DIETHYLNITROSAMINE AND N-ETHYL-N-HYDROXYETHYLNITROSAMINE
M. Yaono et al., HEPATOCYTE GROWTH-FACTOR ENHANCEMENT OF PRENEOPLASTIC HEPATIC FOCI DEVELOPMENT IN RATS TREATED WITH DIETHYLNITROSAMINE AND N-ETHYL-N-HYDROXYETHYLNITROSAMINE, Japanese journal of cancer research, 86(8), 1995, pp. 718-723
Effects of hepatocyte growth factor were investigated in a two-stage r
at liver carcinogenesis protocol. Male F344 rats were first treated wi
th diethylnitrosamine (200 mg/kg, i.p.) and then, starting two weeks l
ater, with N-ethyl-N-hydroHyethylnitrosamine (EHEN) for 6 weeks at a d
ose of 0.01% in drinking water. Hepatocyte growth factor, which was in
jected i.v. at a dose of 200 mu g/kg body weight one (at week 3) or tw
o times (at weeks 3 and 4) during EHEN administration, significantly i
ncreased the development of preneoplastic glutathione S-transferase pl
acental form-positive foci. Although the observed effects of hepatocyt
e growth factor were weaker than that of the two-thirds partial hepate
ctomy (PH) performed at week 3, the present results suggest that the e
nhancing effects of PH performed during the promotion stage may be lar
gely mediated through induction of hepatocyte growth factor.